IDEAYA Biosciences, Inc. — Investor Relations & Filings
Filings indexed
465
across all filing types
Latest filing
2026-06-01
Regulatory Filings
Country
US
United States of America
Listing
US
IDYA
IDEAYA Biosciences, Inc. is a clinical-stage precision medicine oncology company focused on the discovery, development, and commercialization of targeted therapeutics for cancer. The company's primary scientific approach is synthetic lethality, an emerging class of precision medicine that targets cancer cells based on specific genetic alterations. IDEAYA develops potential first-in-class and best-in-class therapies for patient populations selected using molecular diagnostics. Its integrated platform combines capabilities in target and biomarker discovery with the development of small molecule and protein degrader therapeutics to address unmet needs in cancer treatment.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-06-01 | English | |
| S-3ASR - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-05-05 | English | |
| 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-05-05 | English | |
| 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-04-13 | English | |
| 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-04-09 | English | |
| SCHEDULE 13G/A - IDEAYA Biosciences, Inc. (0001676725) (Subject) | 2026-03-27 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47923319 | 8-K | 2026-06-01 | English | ||
| 41528732 | S-3ASR - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-05-05 | English | ||
| 41325620 | 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-05-05 | English | ||
| 34403025 | 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-04-13 | English | ||
| 33898483 | 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-04-09 | English | ||
| 33061067 | SCHEDULE 13G/A - IDEAYA Biosciences, Inc. (0001676725) (Subject) | 2026-03-27 | English | ||
| 32896471 | 4 - IDEAYA BIOSCIENCES, INC. (0001676725) (Filer) | 2026-03-03 | English | ||
| 32896472 | 8-K - IDEAYA BIOSCIENCES, INC. (0001676725) (Filer) | 2026-02-17 | English | ||
| 31258355 | 10-K Filing | 2026-02-17 | English | ||
| 31258163 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 19424576 | SCHEDULE 13G/A - IDEAYA Biosciences, Inc. (0001676725) (Subject) | 2026-02-12 | English | ||
| 31258199 | 4 Filing | 2026-02-02 | English | ||
| 31258190 | 4 Filing | 2026-02-02 | English | ||
| 31258189 | 4 Filing | 2026-02-02 | English | ||
| 31258159 | 4 Filing | 2026-02-02 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CATALYST PHARMACEUTICALS, INC.
Biopharmaceutical company commercializing drugs for rare ne…
|
CPRX | US | Manufacturing |
|
cbdMD, Inc.
Producer and distributor of health and wellness CBD product…
|
YCBD | US | Manufacturing |
|
CCSB
Specialized manufacturer of APIs for oncology, antifungal, …
|
1762 | TW | Manufacturing |
|
CDT Equity Inc.
A clinical-stage biopharmaceutical firm advancing assets fo…
|
CDT | US | Manufacturing |
|
Ceapro Inc.
Develops and commercializes natural active ingredients deri…
|
CZO | CA | Manufacturing |
|
CELADON PHARMACEUTICALS PLC
Researches, cultivates, and manufactures cannabinoid-based …
|
CEL | GB | Manufacturing |
|
Celemics, Inc.
Develops NGS target enrichment solutions for research and c…
|
331920 | KR | Manufacturing |
|
Cellbion Co., Ltd
Develops radiopharmaceuticals and radioligand therapies for…
|
308430 | KR | Manufacturing |
|
CELL BIOTECH CO ., LTD
Develops and manufactures probiotic solutions using patente…
|
049960 | KR | Manufacturing |
|
Celldex Therapeutics, Inc.
Develops antibody-based immunotherapies for severe inflamma…
|
CLDX | US | Manufacturing |
IDEAYA Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31547/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31547 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31547 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31547 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31547}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IDEAYA Biosciences, Inc. (id: 31547)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.